Cytosorbents Corporation
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $17.3M | $5.2M | $5.3M | $3.6M | $2.2M | $1.7M | $1.2M | $1.1M |
| Accounts Receivable | $2.2M | $1.4M | $648.9K | $819.2K | — | — | $36.1K | — |
| Inventory | $795.7K | $834.0K | $1.2M | $537.6K | $245.6K | $682.4K | $431.0K | — |
| Total Current Assets | $20.7M | $7.8M | $9.9M | $7.6M | $3.5M | $2.9M | $1.7M | $1.4M |
| Property, Plant & Equipment | $1.4M | $569.4K | $557.3K | $245.8K | $144.4K | $145.6K | $155.1K | $144.1K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $1.8M | — | — | — | — | — | — | — |
| Total Assets | $24.1M | $9.7M | $11.3M | $8.5M | $4.0M | $3.3M | $2.1M | $1.8M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $1.3M | $684.6K | $698.3K | $786.5K | $800.7K | $675.2K | $817.7K |
| Total Current Liabilities | $7.8M | $4.3M | $3.0M | $4.5M | $3.1M | $2.1M | $1.5M | $1.2M |
| Long-Term Debt | $6.0M | $4.1M | $0 | — | — | — | — | — |
| Total Liabilities | $13.8M | $8.4M | $3.0M | $1.5M | $3.1M | $2.1M | $1.8M | $2.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-152.3M | $-143.5M | $-132.5M | $-124.4M | $-105.8M | — | — | — |
| Total Stockholders' Equity | $10.3M | $1.3M | $9.8M | $6.9M | $-14.3M | $-11.6M | $-10.1M | $-8.1M |